RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (RLMD)

CUSIP: 75955J402

Q2 2026 13F Holders as of 30 Jun 2026

Holder snapshot 5 signals
Share change
+566
SEC-reported price per share
$6.92
Number of holders
2
Value change
+$3,917
Number of buys
2
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
103,817,091

Security key

75955J402

Report period

Q2 2026

Institutions

2

Top holders

2

Ownership snapshot

Top reported holders of RLMD - RELMADA THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
JANUS HENDERSON GROUP PLC
Disclosed value leader
JANUS HENDERSON GROUP PLC
Comparable rows
15/15
Latest evidence
16 Jun 2026
13F 13D/G Lead comparable stake: 10% 13D/G row: JANUS HENDERSON GROUP PLC Showing 1-6 of 15 holder rows.

Quick read

JANUS HENDERSON GROUP PLC leads the comparable SEC ownership view at 10%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens JANUS HENDERSON GROUP PLC's linked filing trail.
Comparable ownership Top 5
JANUS HENDERSON GROUP PLC 10%
Squadron Capital Management LLC 9.9%
Venrock Healthcare Capital Partne... 6.2%
Spruce Street Capital LP 5.6%
Commodore Capital LP 5.1%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
JANUS HENDERSON GROUP PLC
13F 13D/G
Company
10%
from 13D/G
$76,892,206
11,063,862 shares
31 Mar 2026
Squadron Capital Management LLC
13F 13D/G
Company · Squadron Master Fund LP
9.9%
from 13D/G
$58,983,014
8,474,571 shares
31 Mar 2026
Venrock Healthcare Capital Partners III, L.P.
13D/G
6.2%
$46,925,802
6,508,433 shares
$0 02 Jun 2026
Spruce Street Capital LP
13F 13D/G
Company
5.6%
from 13D/G
$42,998,208
6,262,114 shares
31 Mar 2026
Commodore Capital LP
13D/G 13F
Company
5.1%
$40,630,789
5,505,527 shares
$0 27 Apr 2026
Ikarian Capital, LLC
13F 13D/G
Company
4.8%
from 13D/G
$18,710,978
2,688,359 shares
31 Mar 2026
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
2
Shares
566
Rows available
2
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q1 2026 Across Filers

Q1 2026 holders
102
Q2 2026 holders
2
Holder diff
-100
Investor Q1 2026 Shares Q2 2026 Shares Share Diff Share Chg % Q1 2026 value Q2 2026 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .